Business Context and Reporting Period
This Form 8-K, filed on October 22, 1997, by E. I. du Pont de Nemours and Company (DuPont), reports third-quarter and nine-month financial results for the period ended September 30, 1997. The filing includes an earnings press release detailing segment performance, significant nonrecurring charges related to acquisitions and divestitures, and strategic updates regarding the company's portfolio.
Key Financial Metrics
| Metric | Q3 1997 | Q3 1996 | 9 Months 1997 | 9 Months 1996 |
|---|---|---|---|---|
| Sales | $11.1 billion | $10.5 billion | $33.7 billion | $32.4 billion |
| Net Income (Reported) | ($17) million | $898 million | $2.1 billion | $2.8 billion |
| EPS (Reported) | ($0.02) | $0.80 | $1.89 | $2.47 |
| Net Income (Excl. Nonrecurring) | $981 million | $945 million | $3.1 billion | $2.9 billion |
| EPS (Excl. Nonrecurring) | $0.86 | $0.84 | N/A | N/A |
| Dividends Per Share | $0.315 | $0.285 | $0.915 | $0.83 |
Segment Performance (Q3 1997 vs. 1996, excluding nonrecurring items):
- Chemicals: Earnings $154 million (up 12%); Sales up 4%.
- Fibers: Earnings $238 million (up 16%); Sales up 9%.
- Polymers: Earnings $228 million (up 7%); Sales up 7%.
- Petroleum: Earnings $282 million (up 10%, a record); Sales up 8%.
- Life Sciences: Earnings $122 million (down 7% adjusted); Sales down 9%.
- Diversified Businesses: Earnings $52 million (up 30%); Sales down 3%.
Material Changes vs. Prior Period
Reported net income for the third quarter turned to a loss of $17 million compared to $898 million in the prior year, primarily due to $998 million in nonrecurring charges. Excluding these items, underlying earnings grew 4% year-over-year to $981 million. On a year-to-date basis, adjusted net income increased 9% to $3.1 billion.
Key drivers of change include:
- Volume Growth: Strong volume increases in Chemicals (8%), Fibers (12%), and Petroleum (11% refined products) offset lower selling prices driven by a stronger U.S. dollar.
- Nonrecurring Charges: A $850 million charge for in-process R&D from the Pioneer Hi-Bred acquisition and a $220 million charge for the divestiture of printing and publishing businesses.
- Life Sciences Decline: Adjusted earnings fell 7% due to lower Agricultural Products results, partially offset by higher pharmaceutical earnings.
Guidance, Outlook, and Risks
Management Commentary: CEO John A. Krol highlighted that underlying business performance reached record levels, driven by volume growth in Chemicals and Specialties and record earnings in Petroleum. The company is pursuing long-term strategies through major acquisitions and divestitures to create shareholder value.
Strategic Moves:
- Acquired a 20% interest in Pioneer Hi-Bred International, Inc. for approximately $1.7 billion.
- Announced an agreement to divest the hydrogen peroxide business.
- Formed two new ventures with American Electric Power for energy management.
Risks and Contingencies:
- Currency Impact: A stronger dollar reduced average selling prices by 3% in Chemicals and Fibers segments.
- Commodity Prices: Crude oil prices averaged $17.96 per barrel, 10% lower than the prior year, impacting Petroleum margins despite volume gains.
- Product Liability: A $47 million charge in Q3 and $110 million year-to-date related to the "Benlate" 50 DF fungicide recall.
- Valuation Uncertainty: The $850 million Pioneer R&D charge is based on preliminary assumptions subject to revision after independent valuation.
Investor Verification Checklist
- Verify the final independent valuation of the Pioneer Hi-Bred in-process R&D to confirm the $850 million charge.
- Monitor the completion and terms of the divestiture of the global graphic arts films and offset printing plates businesses.
- Assess the impact of the stronger U.S. dollar on future selling prices in international markets.
- Track the resolution of the "Benlate" fungicide recall and associated litigation costs.
- Review the integration progress of the new energy management ventures with American Electric Power.